Beta Bionics, Inc. (BBNX) NASDAQ

9.95

+0.02000034(+0.20%)

Updated at April 06 04:00PM

Currency In USD

Valuation

Market Cap1.23B
Enterprise Value1.22B
P/E Ratio-5.51
PEG Ratio-0.95
Price/Sales Ratio4.4
Price/Book Ratio1.4
Enterprise/Revenue4.16
Enterprise/EBITDA-6.6

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.73
Operating Margin-0.72

Management Effectiveness

Return On Assets-0.22
Return On Equity-0.24

Income Statement

Revenue100.25M
Revenue/Share2.47
Gross Profit55.54M
EBITDA-73.2M
Net Income-73.2M
Diluted EPS-1.81

Balance Sheet

Total Cash219.23M
Total Cash/Share5.41
Total Debt7.3M
Total Debt/Equity0.03
Current Ratio8.66
Book Value Per Share7.1

Price History

52-Week Change-4.69
52-Week High32.71
52-Week Low9.37
Moving Average 50 Days12.37
Moving Average 200 Days19.46

Statistics

Average Volume1.31M
Shares Outstanding44.38M
% Held by Institutions108.22

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A